| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00179439 |
| P698 | PubMed publication ID | 4066227 |
| P2093 | author name string | W Scheithauer | |
| H Ludwig | |||
| E Maida | |||
| P2860 | cites work | Cerebellar vincristine toxicity (author's transl) | Q28320815 |
| Vincristine and prednisone for the induction of remissions in acute childhood leukaemia | Q28365097 | ||
| Vincristine treatment of advanced cancer: a cooperative study of 392 cases. | Q33463170 | ||
| Neurotoxicity of commonly used antineoplastic agents (second of two parts). | Q39901177 | ||
| Vincristine therapy. | Q39967131 | ||
| The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies | Q42231739 | ||
| Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone | Q42232097 | ||
| Seizures associated with vincristine sulfate therapy | Q42233254 | ||
| Vincristine neurotoxicity with hyponatremia | Q42236373 | ||
| Neurofibrillary degeneration induced by vincristine therapy | Q42239707 | ||
| Unilateral seizures following vincristine intravenous injection. | Q42249104 | ||
| Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). | Q53811254 | ||
| Additive toxicity of vincristine and other drugs for the peripheral nervous system. Three case reports. | Q54050507 | ||
| Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells. | Q54391780 | ||
| Effective treatment of advanced multiple myeloma refractory to alkylating agents. | Q54474339 | ||
| Vincristine neurotoxicity | Q68645661 | ||
| Pathogenesis of epileptiform seizures in acute leucosis in childhood | Q71848577 | ||
| Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion | Q72868634 | ||
| A Note on the Selective Toxicity of Vincristine Sulfate on Chick-Embryo Sensory Ganglia in Tissue Culture2 | Q72882421 | ||
| Vincristine neurotoxicity | Q95787563 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 315-318 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report | |
| P478 | volume | 3 |
| Q92865754 | Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review |
| Q80201811 | Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors |
| Q28564505 | Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats |
| Q42277673 | Peripheral neuropathy induced by intravenous administration of vincristine sulfate in the rabbit. An ultrastructural study |
| Q39768346 | Pharmacokinetics of anticancer drugs in children |
| Q31420080 | Subacute central nervous system degeneration in a child: an unusual manifestation of ifosfamide intoxication |
| Q38274890 | The double-edged sword: Neurotoxicity of chemotherapy |
| Q43673144 | VAD protocol for treatment of advanced refractory multiple myeloma |
| Q40040364 | Vincristine and lomustine induce apoptosis and p21(WAF1) up-regulation in medulloblastoma and normal human epithelial and fibroblast cells. |
| Q39752416 | Vincristine neurotoxicity. Pathophysiology and management. |
| Q28374641 | Vincristine revisited |
Search more.